Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year, sales was SEK 37.39 million compared to SEK 28.89 million a year ago. Revenue was SEK 39.33 million compared to SEK 29.58 million a year ago. Net loss was SEK 8.58 million compared to SEK 12.24 million a year ago. Basic loss per share from continuing operations was SEK 0.12 compared to SEK 0.17 a year ago.